Advertisement
Screener

STERIS plc (STE) Income (Loss) from Continuing Operations, Per Diluted Share

2.8 / 5 stars · 68/120 Roast Me

STERIS plc Income (Loss) from Continuing Operations, Per Diluted Share

STERIS plc (STE) reported Income (Loss) from Continuing Operations, Per Diluted Share of $2.04 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-07

  • STERIS plc income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was $2.04, a 13.97% increase year-over-year.
  • STERIS plc income (loss) from continuing operations, per diluted share for the quarter ending 2025-12-31 was $1.96, a 12.00% increase year-over-year.
  • STERIS plc income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was $1.94, a 28.48% increase year-over-year.
  • STERIS plc income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was $1.79, a 26.95% increase year-over-year.
  • STERIS plc income (loss) from continuing operations, per diluted share for fiscal 2026 was $7.93, a 28.73% increase from fiscal 2025.
  • STERIS plc income (loss) from continuing operations, per diluted share for fiscal 2025 was $6.16, a 10.99% increase from fiscal 2024.
  • STERIS plc income (loss) from continuing operations, per diluted share for fiscal 2024 was $5.55, a 0.18% decline from fiscal 2023.
  • STERIS plc income (loss) from continuing operations, per diluted share for fiscal 2023 was $5.56, a 91.72% increase from fiscal 2022.
Period endIncome (Loss) from Continuing Operations, Per Diluted Share 3 monthIncome (Loss) from Continuing Operations, Per Diluted Share 6 monthIncome (Loss) from Continuing Operations, Per Diluted Share 9 monthIncome (Loss) from Continuing Operations, Per Diluted Share 12 month
2026-06-30$2.04
10-Q · filed 2026-08-07
2026-03-31$7.93
10-K · filed 2026-05-29
2025-12-31$1.96
10-Q · filed 2026-02-06
$5.69
10-Q · filed 2026-02-06
2025-09-30$1.94
10-Q · filed 2025-11-06
$3.74
10-Q · filed 2025-11-06
2025-06-30$1.79
10-Q · filed 2026-08-07
2025-03-31$6.16
10-K · filed 2026-05-29
2024-12-31$1.75
10-Q · filed 2026-02-06
$4.68
10-Q · filed 2026-02-06
2024-09-30$1.51
10-Q · filed 2025-11-06
$2.92
10-Q · filed 2025-11-06
2024-06-30$1.41
10-Q · filed 2025-08-07
2024-03-31$1.54
10-K · filed 2024-05-29
$5.55
10-K · filed 2026-05-29
2023-12-31$1.49
10-Q · filed 2025-02-07
$4.01
10-Q · filed 2025-02-07
2023-09-30$1.20
10-Q · filed 2024-11-07
$2.52
10-Q · filed 2024-11-07
2023-06-30$1.31
10-Q · filed 2024-08-08
2023-03-31$1.83
10-K · filed 2024-05-29
$5.56
10-K · filed 2025-05-29
2022-12-31$1.31
10-K · filed 2024-05-29
2022-09-30$1.24
10-K · filed 2024-05-29
2022-06-30$1.19
10-K · filed 2024-05-29
2022-03-31$2.90
10-K · filed 2024-05-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B